Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals

Alzheimer’s disease biomarkers are primarily evaluated through MRI, PET and CSF methods in order to diagnose and monitor disease. Recently, advances in the assessment of blood-based biomarkers have shown promise for simple, inexpensive, accessible and minimally invasive tools with diagnostic and pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Brain Commun
Main Authors: Lussier, Firoza Z, Benedet, Andréa L, Therriault, Joseph, Pascoal, Tharick A, Tissot, Cécile, Chamoun, Mira, Mathotaarachchi, Sulantha, Savard, Melissa, Ashton, Nicholas J, Karikari, Thomas K, Rodriguez, Juan Lantero, Snellman, Anniina, Bezgin, Gleb, Kang, Min Su, Fernandez Arias, Jaime, Wang, Yi-Ting, Gauthier, Serge, Zetterberg, Henrik, Blennow, Kaj, Rosa-Neto, Pedro
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088291/
https://ncbi.nlm.nih.gov/pubmed/33959711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcab073
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados